Latest News

Compound reverses symptoms of Alzheimer's disease in mice

Research in an animal model supports the potential therapeutic value of an antisense compound to treat Alzheimer's disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory. The article is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer's disease in humans.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Study of Lou Gehrig's disease shifts 'origin' focus to brain's motor neurons

  • Humans' big brains might be due in part to newly identified protein

  • Molecular time signalling controls stem cells during brain's development

  • New approach for treating ALS: Re-evaluation of older drugs?

  • Weight, eating habits in Parkinson's disease

  • Reprogramming 'support cells' into neurons could repair injured adult brains

  • Scientists prevent memory problems caused by sleep deprivation

  • Improving memory by suppressing a molecule that links aging to Alzheimer's disease

  • Alzheimer's drug may reduce urge to binge eat

  • Acculturative stress found to be root cause of high depression rates in Latino youth

  •